Pulmonary hypertension (PH) is a pathophysiological disorder that may involve multiple
clinical conditions and may be associated with a variety of cardiovascular and respiratory …

Patients with chronic lung diseases, particularly interstitial lung disease and chronic
obstructive pulmonary disease, frequently develop pulmonary hypertension, which results in …

Background Among patients meeting diagnostic criteria for idiopathic pulmonary arterial
hypertension (IPAH), there is an emerging lung phenotype characterised by a low diffusion …

The term idiopathic pulmonary arterial hypertension (IPAH) is used to categorize patients
with pre-capillary pulmonary hypertension of unknown origin. There is considerable …

Although it is a rare disease, the number of available therapeutic options for treating
pulmonary arterial hypertension has increased since the late 1990s, with multiple drugs …

Pulmonary arterial hypertension (PAH) is a severe but treatable form of pre-capillary
pulmonary hypertension caused by pulmonary vascular remodelling. As a result of basic …

Major advances in pulmonary arterial hypertension, pulmonary hypertension (PH)
associated with lung disease, and chronic thromboembolic PH cast new light on the …

There is a need for clinical trial end-points to better assess how patients feel and function, so
that interventions can be developed which alleviate symptoms and improve quality of life …

Objective Data on the magnitude of benefit of modern therapies for pulmonary arterial
hypertension (PAH) in connective tissue disease (CTD)–associated PAH are limited. In this …

Pulmonary hypertension in interstitial lung disease: screeni... : Current Opinion in
Pulmonary Medicine Pulmonary hypertension in interstitial lung disease: screening …